| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/09/2009 | CA2698688A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2698687A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2696417A1 Therapeutic antibody purification method and method of use |
| 04/09/2009 | CA2694322A1 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/09/2009 | CA2694313A1 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
| 04/09/2009 | CA2694288A1 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/08/2009 | EP2045267A2 Humanized antibodies that recognize beta amyloid peptide |
| 04/08/2009 | EP2045244A1 Novel crystal of substituted phenylalkanoic acid and production process |
| 04/08/2009 | EP2045243A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof |
| 04/08/2009 | EP2044944A1 Nootropic medicinal agent |
| 04/08/2009 | EP2044940A2 Methods of treating patients suffering from movement disorders |
| 04/08/2009 | EP2044937A1 ANALGESIC 5, 9 - METHANOCYCLOOCTA (b) PYRIDIN - 2 (1H) - ONE DERIVATIVES, THEIR PREPARATION METHOD AND USE |
| 04/08/2009 | EP2044072A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia |
| 04/08/2009 | EP2044049A2 Process for the preparation of enantiomerically pure salts of n-methyl- 3 -( 1-naph-thaleneoxy)- 3 - (-2-thienyl) propanamine |
| 04/08/2009 | EP2044043A1 1- ý[- (2, 4-dimethylphenylsulfanyl) -phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment |
| 04/08/2009 | EP2044038A2 Novel piperazines, pharmaceutical compositions and methods of use thereof |
| 04/08/2009 | EP2044029A1 Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2-methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine |
| 04/08/2009 | EP2044020A1 Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
| 04/08/2009 | EP2044019A1 3-oxoisoindoline-1-carboxamide derivatives as analgesic agents |
| 04/08/2009 | EP2044018A1 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 04/08/2009 | EP2043745A2 Treatment of pain disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine and its formamide |
| 04/08/2009 | EP2043687A2 Anti-amyloid antibodies, compositions, methods and uses |
| 04/08/2009 | EP2043671A2 Method and compositions for treating stroke with fever |
| 04/08/2009 | EP2043668A2 Use of echinacea or preparations thereof in compositions for the treatment of anxiety |
| 04/08/2009 | EP2043656A2 New medical use of triazine derivatives |
| 04/08/2009 | EP2043655A2 Purine and deazapurine derivatives as pharmaceutical compounds |
| 04/08/2009 | EP2043654A2 Thienopyrimidines useful as modulators of ion channels |
| 04/08/2009 | EP2043650A2 Treatment for demyelinating disease |
| 04/08/2009 | EP2043642A2 Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing physical performance |
| 04/08/2009 | EP2043641A2 Combinations of monoamine reuptake inhibitors and potassium channel activators |
| 04/08/2009 | EP2043638A2 Use of trifluoromethyl substituted benzamides in the treatment of neurological disorders |
| 04/08/2009 | EP2043632A2 New indications for direct thrombin inhibitors |
| 04/08/2009 | EP2043625A1 Nfkappab inhibitors to treat pain locally |
| 04/08/2009 | EP2043624A2 Combination of modafinil and an antagonist or inverse agonist of the h3 receptor |
| 04/08/2009 | EP1799248B1 Use of il-17f for the treatment and/or prevention of neurologic diseases |
| 04/08/2009 | EP1706114A4 Chemical inhibitors of soluble adenylyl cyclase (sac) |
| 04/08/2009 | EP1565475B1 Diazinopyrimidines and their use as protein kinase inhibitors |
| 04/08/2009 | EP1545710B1 Use of n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide in the treatment of cancer |
| 04/08/2009 | EP1499329B1 Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass |
| 04/08/2009 | EP1461013A4 Method of producing a nicotine composition |
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/08/2009 | EP1442026B1 Triazole derivatives as cyclooxygenase (cox) inhibitors |
| 04/08/2009 | EP1441708B1 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 04/08/2009 | EP1415986B1 Spiro isobenzofuranes as neuropeptide y receptor antagonists |
| 04/08/2009 | EP1265868B1 Preparation of DIBENZO[B,F]AZEPINE INTERMEDIATES |
| 04/08/2009 | EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 04/08/2009 | EP1059925B1 Ep2-receptor agonists as neuroprotective agents for the eye |
| 04/08/2009 | EP0719152B2 Novel therapeutic and dietetic uses of a brain phospholipid-based complex |
| 04/08/2009 | EP0566709B3 Composition comprising a tramadol compound and acetaminophen, and its use |
| 04/08/2009 | CN101405290A Polymorphs of Eszopiclone malate |
| 04/08/2009 | CN101405054A Compositions and methods for preserving brain function |
| 04/08/2009 | CN101405021A Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents |
| 04/08/2009 | CN101405001A Methods of inhibiting BTK and SYK protein kinases |
| 04/08/2009 | CN101404996A Composition containing lignan compound |
| 04/08/2009 | CN101404995A Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 04/08/2009 | CN101402955A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 04/08/2009 | CN101402691A Preparation method for prepared rehmannia root polysaccharide |
| 04/08/2009 | CN101402636A Propellane compounds, preparation method and application thereof |
| 04/08/2009 | CN101402565A Halogenated 2-(a-hydroxyl pentyl) benzoate, production method and uses thereof |
| 04/08/2009 | CN101401923A Oral medicine for headache and general edema in pregnancy period |
| 04/08/2009 | CN101401906A Anshen oral liquid for treating aypnia |
| 04/08/2009 | CN101401874A Lozenge for refreshing oneself and preparation method thereof |
| 04/08/2009 | CN101401855A Method for extracting antianxity substance from spina date seed |
| 04/08/2009 | CN101401854A Medicament formulation for treating epilepsy and preparation thereof |
| 04/08/2009 | CN101401840A Piny flower kudzu root slice prescription for relieving or neutralizing the effect of alcohol to protect liver and preparation thereof |
| 04/08/2009 | CN101401839A Medicament composition for preventing birth-defect and improving memory |
| 04/08/2009 | CN101401838A Medicament composition for preventing birth-defect and improving memory |
| 04/08/2009 | CN101401837A Medicament composition for preventing birth-defect and improving memory |
| 04/08/2009 | CN101401836A Medicament composition for preventing birth-defect and improving memory |
| 04/08/2009 | CN101401835A Medicament composition for preventing birth-defect and improving memory |
| 04/08/2009 | CN101401827A Sedation pharmaceutical use of paecilomyces Gunnii mycelium and its extract |
| 04/08/2009 | CN101401796A Pramipexole orally disintegrating tablets and preparation method thereof |
| 04/08/2009 | CN101401645A Medicament composition for preventing birth-defect and improving memory |
| 04/08/2009 | CN101401644A Medicament composition for preventing birth-defect and improving memory |
| 04/08/2009 | CN101401603A Tea for relieving or neutralizing the effect of alcohol to protect liver |
| 04/08/2009 | CN100475939C A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement and an animal feed product |
| 04/08/2009 | CN100475846C Improved secretion of neublastin |
| 04/08/2009 | CN100475813C 4-oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor |
| 04/08/2009 | CN100475796C Thiazole derivatives as cannabinoid receptor modulators |
| 04/08/2009 | CN100475795C Heterocyclic compounds useful as nurr-1 activators |
| 04/08/2009 | CN100475793C Quinazoline derivatives and use for preparing medicine |
| 04/08/2009 | CN100475792C Novel gamma-secretase inhibitors |
| 04/08/2009 | CN100475786C 4-hydroxy valeramide compounds, prepn. method and use thereof |
| 04/08/2009 | CN100475217C Use of Ocotillol in preparing a drug-dropping and intelligence-promoting medicine |
| 04/08/2009 | CN100475210C Modified release multiple-units dosage composition |
| 04/08/2009 | CN100475205C Use of AR-A014418 in preparing medicine for preventing and treating nerve degenerative diseases |
| 04/08/2009 | CN100475065C Beverage for eliminating alcoholism and preventing alcohol liver and preparation method thereof |
| 04/07/2009 | US7514583 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 04/07/2009 | US7514571 Bicyclo derivative |
| 04/07/2009 | US7514567 Oxazolidinone nicotinic acetylcholine receptor agonists |
| 04/07/2009 | US7514543 Immunoglobulin fusion for use as therapeutic tool in prevention and treatment of chronic progression of atherosclerosis in diabetic patients |
| 04/07/2009 | US7514542 Collagen-like protein CLAC, precursor thereof and genes encoding the same |
| 04/07/2009 | US7514541 crosslinking with curing agents in acidic or alkaline conditions, to form to products used in cosmetic, medical and pharmaceutical applications |
| 04/07/2009 | US7514475 Benzylamine analogues |
| 04/07/2009 | US7514469 Cyclooxygenase inhibitors; osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse |
| 04/07/2009 | US7514459 Gamma-secretase inhibitors |
| 04/07/2009 | US7514456 Nicotinamide derivatives useful as p38 inhibitors |
| 04/07/2009 | US7514454 Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders |
| 04/07/2009 | US7514449 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 04/07/2009 | US7514445 Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors) |